These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19067369)

  • 1. Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.
    Hylek EM; Becker RC
    Ann Neurol; 2008 Nov; 64(5):480-3. PubMed ID: 19067369
    [No Abstract]   [Full Text] [Related]  

  • 2. [Limitations of anticoagulant therapy].
    Martí-Fàbregas J; Delgado-Mederos R; Mateo J
    Neurologia; 2012 Mar; 27 Suppl 1():27-32. PubMed ID: 22682207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
    Martí-Fàbregas J; Mateo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in emerging therapies 2009.
    McArthur K; Lees KR
    Stroke; 2010 Feb; 41(2):e67-70. PubMed ID: 20075349
    [No Abstract]   [Full Text] [Related]  

  • 5. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INR variability in atrial fibrillation: a risk model for cerebrovascular events.
    Amouyel P; Mismetti P; Langkilde LK; Jasso-Mosqueda G; Nelander K; Lamarque H
    Eur J Intern Med; 2009 Jan; 20(1):63-9. PubMed ID: 19237095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ; Andreoli AM; Villani M; Capucci A
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between cardiologists' perceptions and clinical reality of the quality of anticoagulation with vitamin K antagonists in Spain.
    Anguita Sánchez M; Arribas Ynsaurriaga F; Cequier Fillat Á; de Teresa Galván E; Lekuona Goya I; Zamorano Gómez JL
    Rev Esp Cardiol (Engl Ed); 2020 Apr; 73(4):332-334. PubMed ID: 31879233
    [No Abstract]   [Full Text] [Related]  

  • 11. [New concepts of anticoagulant therapy of atrial fibrillation].
    Guedon-Moreau L; Brigadeau F; Kacet S
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1058-62. PubMed ID: 15609907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant therapy in atrial fibrillation: vitamin K antagonists or novel oral anticoagulant drugs?
    Riva N; Borg Xuereb C; Ageno W
    J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):139-41. PubMed ID: 25539157
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
    Vergouwen MD; Vermeulen M; Roos YB
    Neurology; 2009 Apr; 72(16):1447; author reply 1447-8. PubMed ID: 19380708
    [No Abstract]   [Full Text] [Related]  

  • 14. GARFIELD: a window on the real-life treatment of atrial fibrillation - South Africa joins the GARFIELD registry.
    Aalbers J
    Cardiovasc J Afr; 2012 Oct; 23(9):528. PubMed ID: 23108524
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrovascular incidents differ in patients with permanent and paroxysmal atrial fibrillation.
    Staszewski J; Staszewska M; Kotowicz J; Brodacki B; Tomczykiewicz K; Stepien A
    Cerebrovasc Dis; 2006; 22(5-6):446-9. PubMed ID: 16931883
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of stroke in patients with atrial fibrillation and chronic kidney disease: difficult choices and clinical decisions].
    Gorczyca-Michta I; Kluk M; Wożakowska-Kapłon B
    Kardiol Pol; 2012; 70(9):948-52. PubMed ID: 22993008
    [No Abstract]   [Full Text] [Related]  

  • 17. Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes.
    Nieuwlaat R; Connolly SJ
    Heart; 2009 Feb; 95(2):95-7. PubMed ID: 18952632
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
    Lip GY
    Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489
    [No Abstract]   [Full Text] [Related]  

  • 19. Strategies for primary and secondary stroke prevention in atrial fibrillation.
    Finsterer J; Stöllberger C
    Neth J Med; 2008 Sep; 66(8):327-33. PubMed ID: 18809979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.
    Watson T; Kakar P; Lip GY
    Int J Clin Pract; 2007 Jan; 61(1):6-9. PubMed ID: 17229172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.